ANTONIO DOS SANTOS FILHO

(Fonte: Lattes)
Índice h a partir de 2011
3
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina
LIM/51 - Laboratório de Emergências Clínicas, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 10 de 19
  • conferenceObject
    Pathophysiological features of lung and skin in human SSc and collagen V/C57LB6 mouse model
    (2018) TEODORO, W. Paganelli Rosolia; VELOSA, A. P. Pereira; QUEIROZ, Z. A. de Jesus; SANTOS, L. Araujo dos; CATANOZI, S.; SANTOS FILHO, A. dos; BUENO, C.; VENDRAMINI, M. Borges Galhardo; FERNEZLIAN, S. de Moraes; EHER, E. Miristene; LOPES, F. Degobbi T. Q. S.; CAPELOZZI, V. L.
  • conferenceObject
    Type V collagen induced pulmonary fibrosis in C57B1/6mice
    (2014) TEODORO, Walcy Rosolia; VELOSA, Ana Paula Pereira; SANTOS FILHO, Antonio dos; ANDRADE, Priscila Cristina; MARTINS, Vanessa; FERNEZLIAN, Sandra Morais; CATANOZI, Sergio; CAPELOZZI, Vera Luisa
  • article 3 Citação(ões) na Scopus
    Collagen V oral administration decreases inflammation and remodeling of synovial membrane in experimental arthritis
    (2018) ATAYDE, Silvana Ramos; VELOSA, Ana Paula Pereira; CATANOZI, Sergio; BIANCO, Vanessa Del; ANDRADE, Priscila Cristina; RODRIGUES, Jose Eduardo de Castro M.; SANTOS FILHO, Antonio dos; ANTONANGELO, Leila; MELLO, Suzana Beatriz Verissimo de; CAPELOZZI, Vera Luiza; TEODORO, Walcy Rosolia
    Because collagen type V (Col V) can be exposed in tissue injury, we hypothesized that oral administration of this collagen species modulates the inflammation and remodeling of experimental synovitis, avoiding joint destruction, and that the modulation may differ according to the temporal administration. Arthritis (IA, n = 20) was induced in Lewis rats by intraarticular (ia) injection of 500 mu g of methylated bovine serum albumin (mBSA) emulsified in complete Freund's adjuvant (CFA) (10 mu l) followed by an intraarticular booster of mBSA (50 mu g) in saline (50 mu l) administered at 7 and 14 days. The control group received saline (50 mu l, ia). After the first intraarticular injection, ten IA animals were supplemented via gavage with Col V (500 mu g/300 mu l) daily for 30 days (IA/Suppl). The control group received saline (50 mu L) and Col V supplement in the same way (Suppl). Col V oral administration in IA/Suppl led to 1) inhibited edema and severe inflammatory cell infiltration, 2) decreased collagen fiber content, 3) decreased collagen type I, 4) inhibited lymphocyte subpopulations and macrophages, 5) inhibited IL-1 beta, IL-10, IL-17 and TNF-alpha production and 6) increased expression of caspase-9 in the synovial tissue. In conclusion, Col V supplementation decreased synovial inflammation and the fibrotic response, possibly by increased the apoptosis of inflammatory cells.
  • conferenceObject
    COLLAGEN V/C57BL6 MOUSE MODEL: A NOVEL PRECLINICAL MODEL TO STUDY PATHOPHYSIOLOGY AND THERAPEUTIC APPROACHES IN SYSTEMIC SCLEROSIS
    (2018) TEODORO, W. R.; VELOSA, A. P. P.; QUEIROZ, Z. A. de J.; SANTOS, L. A. dos; CATANOZI, S.; SANTOS FILHO, A. dos; BUENO, C.; VENDRAMINI, M.; FERNEZLIAN, S. M.; EHER, E. M.; LOPES, F. D. T. Q. S.; SAMPAIO-BARROS, P. D.; CAPELOZZI, V. L.
  • conferenceObject
    Fibril and network-forming collagen may influence crosslinked density of skin in diabetic rats
    (2016) TEODORO, W. Rosolia; TOLEDO, V. Protocevich; CATANOZI, S.; VELOSA, A. P. Pereira; SANTOS-FILHO, A. dos; CAPELOZZI, V.
  • article 10 Citação(ões) na Scopus
    Post-Adipose-Derived Stem Cells (ADSC) Stimulated by Collagen Type V (Col V) Mitigate the Progression of Osteoarthritic Rabbit Articular Cartilage
    (2021) CRUZ, Isabele Camargo Brindo da; VELOSA, Ana Paula Pereira; CARRASCO, Solange; SANTOS FILHO, Antonio dos; MIRANDA, Jurandir Tomaz de; POMPEU, Eduardo; FERNANDES, Tiago Lazzaretti; BUENO, Daniela Franco; FANELLI, Camila; GOLDENSTEIN-SCHAINBERG, Claudia; FABRO, Alexandre Todorovic; FULLER, Ricardo; SILVA, Pedro Leme; CAPELOZZI, Vera Luiza; TEODORO, Walcy Rosolia
    Collagen is essential for cartilage adhesion and formation. In the present study, histology, immunofluorescence, morphometry, and qRT-PCR suggested that adipose-derived stem cells (ADSCs) stimulated by type V collagen (Col V) induce a significant increase of type II collagen (Col II) in the degenerative area of surgical-induced osteoarthritic rabbit articular cartilage (OA). In vitro, the effects of Col V on the proliferation and differentiation of ADSC were investigated. The expression of the cartilage-related genes Col2a1 and Acan was significantly upregulated and Pou5fl was downregulated post-ADSC/Col V treatment. Post-ADSC/Col V treatment, in vivo analyses revealed that rabbits showed typical signs of osteoarthritic articular cartilage regeneration by hematoxylin and eosin (H&E) and Safranin O/Fast Green staining. Immunohistochemical staining demonstrated that the volume of Col II fibers and the expression of Col II protein were significantly increased, and apoptosis Fas ligand positive significantly decreased post-ADSC/Col V treatment. In conclusion, the expression of Col II was higher in rabbits with surgical-induced osteoarthritic articular cartilage; hence, ADSC/Col V may be a promising therapeutic target for OA treatment.
  • conferenceObject
    Collagen V-induced nasal tolerance increase FOXp3 in systemic sclerosis model
    (2012) TEODORO, W.; VELOSA, A. P.; CRUZ, I. Brindo da; SANTOS FILHO, A.; FERNEZLIAN, S.; PARRA, E.; YOSHINARI, N.; CAPELOZZI, V.
    Objective: To evaluate FOXp3 expression in bronchus-associated lymphoid tissue (BALT) and correlate with the inflammatory process and collagen content in the lung tissue in an experimental model of scleroderma (SSc) after type V collagen (COL V)-induced nasal tolerance. Method: Female New Zealand rabbits (N=12) were immunized with 1 mg/ml of COL V in Freund’s adjuvant (IM). After 150 days, six immunized animals were nasally tolerated with COL V (25νg/day), during 60 days (IM-TOL). Animals (N=6) only tolerated served as control (CT). FOXP3 expression in BALT and inflammatory cells in pulmonary interstitium were evaluated by point counting method. Types I, III and V collagen gene expression were evaluated by Real-time PCR. Results: IM-TOL when compared to IM presented decreased lymphocytes, macrophages and monocytes and types I (p=0,002) and V (p=0,009) collagen mRNA expression in pulmonary tissue. T lymphocytes FOXp3 were expressed in 100 % of IM-TOL and 33,3 % of CT (p=0,03). Additionally, BALT was higher expressed in IM-TOL in relation to CT. Conclusion: COL V-induced nasal tolerance in SSc model induces FOXp3 regulatory T cells in BALT which can trigger an immune regulatory mechanism resulting in decreased inflammation and collagen expression. It suggests that COL V tolerance could be a promising therapeutic for human scleroderma treatment.
  • conferenceObject
    In situ and humoral sensitivity to native type V collagen in early synovial fibrosis of a rat model of arthritis
    (2019) SILVEIRA, L. K. Ramos da; VELOSA, A. P. Pereira; CATANOZI, S.; SANTOS FILHO, A.; FERNEZLIAN, S.; EHER, E.; MIRANDA, J. Tomaz de; CAPELOZZI, V. L.; TEODORO, W. Rosolia
  • conferenceObject
    Pulmonary and cutaneous remodeling in mice model of systemic sclerosis
    (2016) TEODORO, W. Rosolia; SANTOS, L. Araujo Dos; CATANOZI, S.; ANDRADE, P. C.; SANTOS, A. Filho Dos; FERNEZLIAN, S. De Moraes; EHER, E. Miristene; VELOSA, A. P. Pereira; CAPELOZZI, V. F.
  • conferenceObject
    REMODELING AND CHANGES IN FIBRILLOGENESIS OF COLLAGEN FIBERS IN SYNOVIAL TISSUE FROM DIABETIC RATS
    (2013) GOLDENSTEIN-SCHAINBERG, Claudia; ATAYDE, S. A.; CATANOZI, S.; SANTOS-FILHO, A. Dos; VELOSA, Paula; PARRA, E.; ANDRADE, P. C.; CAPELOZZI, Vera; TEODORO, Walcy